Archives

by in
Entry Author Date Location
Imprivata Buys HT Systems for $19M for Vein-Identifying Device 05/01/15 Boston
East Coast Biotech Roundup: Celgene, Blueprint(s), Intarcia & More 05/01/15 Boston
With $46M Haul, MyoKardia Becomes Third Rock’s Latest IPO Prospect 04/30/15 San Francisco
Blueprint Medicines Bags $147M in Upsized IPO 04/29/15 Boston
Ariad Searches For New Leader As Berger Steps Down, Ending Proxy Battle 04/29/15 Boston
In Venture Reinvention, Versant Sees Gains Amid Biotech Boom Times 04/29/15 National
Intarcia, Still Private, Nabs $225M More For Diabetes Device 04/28/15 Boston
East Coast Biotech Roundup: Forum, Crossovers, Immuno-Oncology & More 04/24/15 Boston
Aerie Craters As Glaucoma Drug Comes up Short in Phase 3 04/23/15 New York
Crossovers Arm Jounce With $56M For “Next Step” Immuno-Oncology 04/23/15 Boston
Innovation Grants and Unsung Life Sciences Startups of San Diego 04/23/15 San Diego
Napa Summit 2015: Request Your Invite to Xconomy’s Most Elite Event 04/22/15 National
Dunsire, Forum Pharma Look Beyond Fidelity For Big Alzheimer’s Push 04/22/15 Boston
ImmuneXcite Enlists Body’s First Defender for Immune Attack on Cancer 04/21/15 Boston
Gene Therapy Upstart Dimension Nabs $65M From “Crossover” Backers 04/21/15 Boston
Intel, Edico Genome Working to Speed Analysis of Genomic Data 04/21/15 San Diego
With Fresh $14M, Tal Seeks Answers About Magnetic Depression Relief 04/21/15 Boston
Alnylam RNAi Drug Holds Up After Year of Treatment in Small Study 04/21/15 Boston
Now Biotech-Only, Atlas Reloads With $280M Fund For New Startups 04/17/15 Boston
Dip, But No Slowdown in First-Quarter VC Funding, & Top 10 Deals 04/17/15 National
Doudna, Berkeley Gain Expert’s Backing In CRISPR Patent Fight 04/15/15 San Francisco
Big Day For Biotech IPOs as Aduro More Than Doubles In Price 04/15/15 San Francisco
Announcing Boston 2035: Innovating the Future Starts Now 04/15/15 Boston
What’s Hot in Boston Biotech: The Photos 04/15/15 Boston
Massachusetts Healthcare, Internet Companies Lead Pack in VC Chase 04/14/15 Boston
Pop That Bubble: 5 Reasons Biotech Needs A Different Metaphor 04/14/15 National
VC Funding Slows as Big Funds Crowd into Late-Stage Venture Deals 04/14/15 National
Curoverse Begins Trial Run for Open Source Genomics Tool 04/14/15 Boston
Hunting for an IPO? Voyager Gets $60M From “Crossover” Backers 04/13/15 Boston
Blend Therapeutics Taps Former Clinical Data Chief Fromkin As New CEO 04/13/15 Boston
Page 1 of 94 next page »